RORγt-expressing tregs drive the growth of colitis-associated colorectal cancer by controlling IL6 in dendritic cells

A Rizzo, M Di Giovangiulio, C Stolfi, E Franzè… - Cancer Immunology …, 2018 - AACR
Chronic inflammation drives colitis-associated colorectal cancer (CAC) in inflammatory
bowel disease (IBD). FoxP3+ regulatory T cells (Treg) coexpressing the Th17-related …

IRAK-M expression in tumor cells supports colorectal cancer progression through reduction of antimicrobial defense and stabilization of STAT3

R Kesselring, J Glaesner, A Hiergeist, E Naschberger… - Cancer cell, 2016 - cell.com
Colorectal cancer (CRC) is associated with loss of epithelial barrier integrity, which
facilitates the interaction of the immunological microenvironment with the luminal …

[HTML][HTML] BET inhibitor JQ1 enhances anti-tumor immunity and synergizes with PD-1 blockade in CRC

H Wang, G Liu, X Jin, S Song, S Chen, P Zhou… - Journal of …, 2022 - ncbi.nlm.nih.gov
Most colorectal cancer (CRC) patients are insensitive to immune checkpoint inhibitors (ICIs)
due to the immunosuppressive tumor microenvironment (TME). Epigenetic factors such as …

The walrus and the carpenter: complex regulation of tumor immunity in colorectal cancer

G Dewson, J Silke - Cell, 2018 - cell.com
Immune infiltration has been correlated with survival of patients with colorectal cancer. In this
issue, Ziegler et al. reveal complex and unexpected connections between loss of STAT3 …

RTP4 silencing provokes tumor-intrinsic resistance to immune checkpoint blockade in colorectal cancer

Y Yamamoto, S Shimada, Y Akiyama… - Journal of …, 2023 - Springer
Background Recent advances in immune checkpoint blockade (ICB) have improved patient
prognosis in mismatch repair-deficient and microsatellite instability-high colorectal cancer …

[HTML][HTML] The complex network of transcription factors, immune checkpoint inhibitors and stemness features in colorectal cancer: A recent update

M Merhi, F Ahmad, N Taib, V Inchakalody… - Seminars in Cancer …, 2023 - Elsevier
Cancer immunity is regulated by several mechanisms that include co-stimulatory and/or co-
inhibitory molecules known as immune checkpoints expressed by the immune cells. In …

Colorectal cancer-infiltrating regulatory T cells: functional heterogeneity, metabolic adaptation, and therapeutic targeting

S Aristin Revilla, O Kranenburg, PJ Coffer - Frontiers in immunology, 2022 - frontiersin.org
Colorectal cancer (CRC) is a heterogeneous disease with one of the highest rates of
incidence and mortality among cancers worldwide. Understanding the CRC tumor …

LIGHT enhanced bispecific antibody armed T-cells to treat immunotherapy resistant colon cancer

G Qiao, LB Kone, EH Phillips, SSY Lee, GE Brown… - Oncogene, 2022 - nature.com
Increased tumor infiltrating lymphocytes (TIL) are associated with improved patient
responses to immunotherapy. As a result, there is interest in enhancing lymphocyte …

Molecular signatures of human regulatory T cells in colorectal cancer and polyps

NA Johdi, K Ait-Tahar, I Sagap, R Jamal - Frontiers in Immunology, 2017 - frontiersin.org
Regulatory T cells (Tregs), a subset of CD4+ or CD8+ T cells, play a pivotal role in regulating
immune homeostasis. An increase in Tregs was reported in many tumors to be associated …

Circulating and Tumor-Infiltrating Immune Checkpoint-Expressing CD8+ Treg/T Cell Subsets and Their Associations with Disease-Free Survival in Colorectal Cancer …

A Alsalman, MA Al-Mterin, K Murshed, F Alloush… - Cancers, 2022 - mdpi.com
Simple Summary Colorectal cancer is one of the leading causes of global cancer-related
mortality. Tumor-infiltrating effector immune cells play critical roles in tumor control, and their …